Syncope, or transient loss of consciousness (TLOC), is a common clinical presentation, accounting for approximately 1-3% of emergency department visits. Despite its prevalence, the diagnosis and management of syncope can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to the evaluation and management of syncope.
Syncope is generally caused by a temporary global reduction in cerebral blood flow. The most common causes include neurally mediated syncope, orthostatic hypotension, and cardiac syncope. The former two are often benign, while the latter may be indicative of life-threatening conditions.
A thorough history and physical examination are paramount in evaluating a patient with syncope. The goal is to identify clues that point towards the underlying cause. Key elements include the circumstances surrounding the event, presence of prodromal symptoms, and family history of sudden cardiac death.
The initial diagnostic approach includes an electrocardiogram (ECG) and routine laboratory tests. Further investigations, such as echocardiography, tilt-table testing, or Holter monitoring, may be warranted based on the clinical suspicion. The use of clinical decision rules, such as the San Francisco Syncope Rule, can aid in risk stratification and guide further management.
The management of syncope is largely guided by the underlying cause. For neurally mediated syncope, patient education and lifestyle modifications are the mainstays of treatment. Pharmacological therapy may be considered in recurrent cases. In contrast, cardiac syncope often warrants a more aggressive approach, including antiarrhythmic therapy or device implantation.
In conclusion, the evaluation and management of syncope necessitate a systematic and comprehensive approach. By understanding the pathophysiology and employing a targeted diagnostic approach, healthcare professionals can effectively manage this common clinical presentation and potentially avert serious outcomes.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation